CPhI Korea Returns to Seoul for Third Year

CPhI Korea will return to the COEX center in Seoul for the third year from August 23–25, 2016. More than 5000 pharmaceutical professionals from 50 countries are expected to attend the three-day conference. CPhI Korea is co-located with ICSE, P-MEC, BioPh, and Health Ingredients Korea.

The CPhI Korea conference includes an assessment of the industry’s present state and future trends. The conference provides a meeting place for a wide-range of industry suppliers, purchasers, and decision makers from the pharmaceutical industry. Exhibitors have the opportunity to showcase products and services during the conference. Visitors also have the ability to schedule meetings using CPhI’s free online service.

CPhI says it expects the exhibitor base will increase by 10% in 2016 to 150, with the number of overseas buyer attendance increasing by 42%. Some notable sessions from the conference include:

• The Latest Information on Japan Pharmacopoeia and Master Files

• The Success Strategy to Enter EU Market With Some Cases of Most Frequent Mistakes for (Korean) Pharmaceutical Companies With Respect to API’s Used

• Generic Medicines: Registration and Pricing Policies in Europe

• Pharmaceutical Market in China

CPhI, Pharmaceutical Technology, and BioPharm International are all UBM plc brands.

Source: CPhI